Contact
searchSearch
HMP Global

Atopic Dermatitis Topic Center

Featured

Atopic dermatitis
News
ADO Gene Implicated in Skin Barrier Dysfunction and Inflammation in Atopic Dermatitis
02/03/2026
Jessica Garlewicz
The findings identify ADO as a potential mechanistic link between genetic risk and epidermal dysfunction in AD.
The findings identify ADO as a potential mechanistic link between genetic risk and epidermal dysfunction in AD.
The findings identify ADO as a...
02/03/2026
The Dermatologist
Atopic dermatitis
News
Self-Assessment Questionnaires Reveal Mental Health Burden in Psoriasis and Atopic Dermatitis
02/03/2026
Jessica Garlewicz
The findings support the use of validated questionnaires to identify psychological distress that may otherwise go unrecognized in dermatology visits.
The findings support the use of validated questionnaires to identify psychological distress that may otherwise go unrecognized in dermatology visits.
The findings support the use of...
02/03/2026
The Dermatologist
Atopic dermatitis
News
Topical Isosorbide Diesters Improve Itch and Reduce Steroid Use in Pediatric Atopic Dermatitis
02/03/2026
Jessica Garlewicz
The findings suggest a potential steroid-sparing adjunct for pediatric AD management.
The findings suggest a potential steroid-sparing adjunct for pediatric AD management.
The findings suggest a potential...
02/03/2026
The Dermatologist
Atopic dermatitis
News
Meta-Analysis Links Atopic Dermatitis to Higher All-Cause and Cause-Specific Mortality
01/22/2026
Jessica Garlewicz
The findings reinforce growing recognition of atopic dermatitis as a systemic inflammatory disease with implications beyond the skin.
The findings reinforce growing recognition of atopic dermatitis as a systemic inflammatory disease with implications beyond the skin.
The findings reinforce growing...
01/22/2026
The Dermatologist
News
Washed Microbiota Transplantation Improves Disease Severity and Microbial Profiles in Moderate-to-Severe Atopic Dermatitis
01/15/2026
Jessica Garlewicz
Washed microbiota transplantation (WMT) was associated with significant clinical improvement and favorable shifts in gut and skin microbiota among patients with moderate-to-severe atopic dermatitis (AD), according to a small prospective study...
Washed microbiota transplantation (WMT) was associated with significant clinical improvement and favorable shifts in gut and skin microbiota among patients with moderate-to-severe atopic dermatitis (AD), according to a small prospective study...
Washed microbiota...
01/15/2026
The Dermatologist
atopic dermatitis
News
Network Meta-Analysis Ranks Oral JAK Inhibitors for Short-Term Control of Moderate-to-Severe Atopic Dermatitis
01/06/2026
Jessica Garlewicz
The findings provide comparative guidance in the absence of head-to-head randomized trials.
The findings provide comparative guidance in the absence of head-to-head randomized trials.
The findings provide comparative...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
Atopic dermatitis
News
Nemolizumab Receives EU Approval for Atopic Dermatitis and Prurigo Nodularis
02/18/2025
Riya Gandhi, MA
New monoclonal antibody offers targeted relief for patients with persistent itch and skin lesions
New monoclonal antibody offers targeted relief for patients with persistent itch and skin lesions
New monoclonal antibody offers...
02/18/2025
The Dermatologist
Atopic dermatitis
News
Tobacco Smoke Exposure Unlikely to Worsen Atopic Dermatitis in Youth
12/23/2024
Riya Gandhi, MA
A comprehensive study finds no significant link between exposure to tobacco smoke and the severity or activity of atopic dermatitis in children and adolescents.
A comprehensive study finds no significant link between exposure to tobacco smoke and the severity or activity of atopic dermatitis in children and adolescents.
A comprehensive study finds no...
12/23/2024
The Dermatologist
Atopic dermatitis
News
Mulberry Extract Shows Promise in Treating Atopic Dermatitis
12/18/2024
Riya Gandhi, MA
A traditional remedy, white mulberry demonstrates therapeutic potential for eczema, offering a natural alternative to chemical treatments.
A traditional remedy, white mulberry demonstrates therapeutic potential for eczema, offering a natural alternative to chemical treatments.
A traditional remedy, white...
12/18/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Tapinarof Cream 1% for Atopic Dermatitis in Adults and Children
12/16/2024
Riya Gandhi, MA
Organon’s VTAMA cream, 1%, offers a steroid-free solution for patients 2 years and older with moderate-to-severe atopic dermatitis, featuring powerful skin clearance and rapid itch relief.
Organon’s VTAMA cream, 1%, offers a steroid-free solution for patients 2 years and older with moderate-to-severe atopic dermatitis, featuring powerful skin clearance and rapid itch relief.
Organon’s VTAMA cream, 1%,...
12/16/2024
The Dermatologist

Multimedia

Fall Clinical AD Roundtable
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following Fall Clinical
11/03/2022
Mona Shahriari, MD, FAAD
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs Swanson, Golant, Ungar, and Shahriari met to discuss the diagnosis, treatment, and management of atopic dermatitis.
​​​​​​In this video, Drs...
11/03/2022
The Dermatologist
Roundtable AAD
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAD
08/15/2022
Amy S. Paller, MD, MS
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022 AAD Annual Meeting, Drs Paller, Friedman, Kwatra, and Blauvelt held a discussion atopic dermatitis following conference.
In this video, live at the 2022...
08/15/2022
The Dermatologist
Drs Friedman, Lio, Shi and Kirkorian
Videos
Expert Roundtable: Insights Into Atopic Dermatitis Following AAAAI
07/15/2022
Adam Friedman, MD; Peter Lio, MD, FAAD; Vivian Shi, MD
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs Friedman, Lio, Shi, and Kirkorian meet to discuss the diagnosis, treatment, and management of atopic dermatitis following the AAAAI 2022 meeting.
In this expert roundtable, Drs...
07/15/2022
The Dermatologist
Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Shawn Kwatra, MD
Videos
ICYM RAD 2022: Dr Kwatra on Itch in Atopic Dermatitis
04/13/2022
Shawn Kwatra, MD
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual Revolutionizing Atopic Dermatitis Conference (RAD), Dr Shawn Kwatra went over managing itch, the efficacy of current treatments, and more during this interview.
Prior to the 4th Annual...
04/13/2022
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation...
02/01/2026
The Dermatologist
Peter Lio
Clinical Insights
Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis
01/20/2026
Peter Lio, MD, FAAD
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how...
01/20/2026
Allergy & Immunology
Stephen D. Hess, MD, PhD
Videos
Electrical Impedance Spectroscopy For Skin Cancer Screening
01/13/2026
Stephen D. Hess, MD, PhD
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he...
01/13/2026
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
Part 3
Videos
Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this...
11/03/2025
The Dermatologist
Katrina Abuabara
Videos
Systemic Treatments for Special Populations in Dermatology
09/10/2025
Katrina Abuabara, MD, MA, MSCE
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares strategies for safely prescribing systemic therapies in special populations with atopic dermatitis—covering pregnancy, older adults, comorbidities, drug interactions, and real-world data limitations.
Dr Katrina Abuabara shares...
09/10/2025
The Dermatologist
part 2
Videos
Part 2: From Topicals to Biologics: Evolution of Treatment Options in Severe Alopecia Areata
09/08/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna.
Explore how the treatment of severe alopecia areata has evolved—from topicals to cutting-edge FDA-approved JAK inhibitors—in this expert-led discussion featuring Drs. Craiglow, King, and Senna.
Explore how the treatment of...
09/08/2025
The Dermatologist
Dr Omid Hamid
Videos
Derm Advances: Insights From Dr Hamid on the Phase 3 C-POST Trial Results
08/15/2025
Omid Hamid, MD
08/15/2025
The Dermatologist
Glynis Ablon, MD, and Neil Sadick, MD presenters
Videos
Expert Perspectives: Hair Loss Management in Dermatology Practice
08/08/2025
Neil S. Sadick, MD, FAAD; Glynis Ablon
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the rising prevalence of hair loss and the expanding range of treatment options available to dermatologists. It outlines the most common hair loss conditions and highlights the emotional and psychological impact on...
This presentation explores the...
08/08/2025
The Dermatologist
George Murakawa
Videos
Infusion Therapy for Non-Melanoma Skin Cancer: A Dermatologist’s Guide
07/31/2025
George J. Murakawa, MD, PhD
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology practice integrates in-office infusion therapy into daily clinical workflows, as this video explores the practical aspects of treating advanced non-melanoma skin cancers with systemic therapy, including a firsthand...
Learn how one dermatology...
07/31/2025
The Dermatologist

From the Issue

Jeff Yu, MD
Videos
Identification and Characterization of Clinical Phenotypes
04/29/2022
Jeff Yu, MD
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how clinical phenotypes in AD are characterized and the challenges that come with identification.
Jeff Yu, MD, discusses how...
04/29/2022
The Dermatologist
Emma Guttman-Yassky, MD, PhD
Feature Story
Positive Results Revealed for Atopic Dermatitis Investigational Drug Etrasimod
10/10/2021
Peter Sonnenreich
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.
Recently presented clinical...
10/10/2021
The Dermatologist
NEA Approved Features
Pop Quiz: Cardiovascular Risk and Atopic Dermatitis
05/17/2021
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most implicated in the pathogenesis of atherosclerosis and AD, respectively?
What immune pathways are most...
05/17/2021
The Dermatologist
NEA Approved Features
Quiz: Pain in Atopic Dermatitis
03/12/2021
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most burdensome symptom of AD, pain can also cause stress and negatively affect quality of life.
While itch is the most...
03/12/2021
The Dermatologist
Partner Approved
Get Eczema Wise During Eczema Awareness Month
10/16/2020
Lauren Mateja
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
As research continues to better...
10/16/2020
The Dermatologist
Feature Story
Dupilumab Treatment Provides Multidimensional Improvement of Signs, Symptoms, and Quality of Life in Children With Severe Atopic Dermatitis: A Pictorial Guide
08/13/2020
Ana B. Rossi, MD, CMD; Brad Shumel, MD
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by Drs Shumel and Rossi demonstrates the efficacy of dupilumab in patients aged 6 to 11 years with severe atopic dermatitis treated over a 16-week period.
This visual 12-patient series by...
08/13/2020
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist
Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist
MASTERCLASSES IN DERMATOLOGY FORUM
Redefining Remission and Low Disease Activity in Dermatology
10/06/2025
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an...
10/06/2025
The Dermatologist
Feature Story
Two Roads Diverging: The Future of Patient Communication in the Era of Artificial Intelligence
09/08/2025
Ross Lane Pearlman, MD
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of large language model applications will affect the dialogue between patients and physicians.
Without a doubt, the rise of...
09/08/2025
The Dermatologist
NEA Approved Features
Eczema Action Plans: Personalized Tools for Empowering Patients and Enhancing Care
09/08/2025
Jessica Garlewicz
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association researchers offer practical guidance grounded in real-world patient and provider needs to optimize long-term atopic dermatitis control and better support patient self-management.
National Eczema Association...
09/08/2025
The Dermatologist
HSF Reviewed Features
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
09/08/2025
Gretchen M. Roth, MD, FAAD; Precious A. Anyanwu
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve hidradenitis suppurativa care and help improve the lives of our patients.
Together, we can improve...
09/08/2025
The Dermatologist
Feature Story
GLP-1 Agonists: Implications for Dermatology
08/02/2025
Serene Majid, BA; Steven R. Feldman, MD, PhD
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an accessible overview of the pharmacologic mechanisms of glucagon-like peptide-1 receptor agonists, the utility of these drugs in obesity, and their potential applications in managing inflammatory skin disease.
This article provides an...
08/02/2025
The Dermatologist
NEA Approved Features
Eczema in the United States: Insights from a National Study on Prevalence and Co-Occurrence
06/05/2025
Lisa Kuhs, PhD
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database highlights the complexity of eczema beyond atopic dermatitis and emphasizes the need for a more nuanced approach in both clinical practice and research.
The All of Us database...
06/05/2025
The Dermatologist
Feature Story
What’s New in Allergic Contact Dermatitis? 2025’s Allergens on the Rise
05/01/2025
Braily Weber, BS, BA; Sara A. Hylwa, MD
Familiarize yourself with up-and-coming allergens, including their chemical function, role in consumer products, and reported cases of contact allergy.
Familiarize yourself with up-and-coming allergens, including their chemical function, role in consumer products, and reported cases of contact allergy.
Familiarize yourself with...
05/01/2025
The Dermatologist
NEA Approved Features
Addressing Acute Care Needs in Atopic Dermatitis: A Call for Improved Access and Management
03/06/2025
Lisa Kuhs, PhD
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association survey examines the frequency of acute care needs among patients with atopic dermatitis and the wait times they experience when seeking care from their primary atopic dermatitis health care providers.
National Eczema Association...
03/06/2025
The Dermatologist
jan/feb issue

Current Issue

January 2026
Volume 34
Issue 1
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use